Leading organisations:
Health Care Without Harm Europe
Timeframe:
2016-ongoing
Geographic Area:
Pan-European
Objectives:
1) To protect the environment from pharmaceutical pollution at all stage of their life cycle, 2) To bring the voice of healthcare professionals to the European policy debate about the issue of pharmaceuticals in the environment.
Target audience:
General Public, Hospitals/health system stakeholders, National/Local decision and policy makers, and Water/waste service providers
Area of interest:
Collection schemes at national level, Emergence of anti-microbial resistance (AMR), Occurrence of pharmaceuticals in the environment, Pharmaceutical consumption by humans, Pharmaceutical manufacturing, Pharmaceutical waste & waste management, Prescription practices, Risks to ecosystems, Risks to human health, Unused/expired pharmaceutical disposal practices, Wastewater, and Water treatment technologies
Activities:
Communication material:
- SaferPharma campaign
- Water reuse and pharmaceutical pollution
- Water reuse management. Is pharmaceutical pollution a real problem?
- Recommendations on pharmaceuticals in the environment – September 2016
- SaferPharma Campaign
- THE ENVIRONMENTAL IMPACT OF PHARMACEUTICAL MANUFACTURING: How does industry address its own waste?
- Webinar | Safer pharma: How healthcare can reduce pharmaceutical pollution
- The environmental impact of pharmaceutical manufacturing: how does industry address its own waste?
- A multistakeholder approach to pharmaceuticals in the environment: working together towards effective solutions
Return to search form.
HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.
